These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 28776339)

  • 1. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
    Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
    J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
    Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
    Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
    Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
    HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea.
    Lee SO; Lee JE; Lee S; Lee SH; Kang JS; Son H; Lee H; Kim J
    Sci Rep; 2022 Jun; 12(1):9974. PubMed ID: 35705675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
    Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O;
    Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
    Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
    Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
    Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
    Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
    Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
    Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
    J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.
    Kim SE; Jung Y; Oh TH; Kim UJ; Kang SJ; Jang HC; Park KH; Lee KH; Jung SI
    BMC Cancer; 2018 Nov; 18(1):1080. PubMed ID: 30409111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
    AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological trends and therapeutic challenges of malignancies in adult HIV-1-infected patients receiving combination antiretroviral therapy in a tertiary hospital from Romania: An observational retrospective study.
    Gheorghiță V; Conea IF; Radu AMC; Ștefan I; Mărdărescu M; Petrea S; Streinu-Cercel A
    J Infect Public Health; 2019; 12(2):182-189. PubMed ID: 30344102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
    International Collaboration on HIV and Cancer
    J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-AIDS-defining cancers among HIV-infected people.
    Pinzone MR; Fiorica F; Di Rosa M; Malaguarnera G; Malaguarnera L; Cacopardo B; Zanghì G; Nunnari G
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1377-88. PubMed ID: 23104654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
    Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
    J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancies in human immunodeficiency virus infected patients in India: Initial experience in the HAART era.
    Sharma SK; Soneja M; Ranjan S
    Indian J Med Res; 2015 Nov; 142(5):563-7. PubMed ID: 26658591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.